Natalie S Callander Selected Research

Natalie S Callander Research Topics

Disease

31	Multiple Myeloma 09/2022 - 05/2003
16	Neoplasms (Cancer) 08/2022 - 05/2003
6	Disease Progression 10/2019 - 01/2010
4	Residual Neoplasm 09/2022 - 01/2021
3	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 01/2005
3	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 03/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2021
2	Bone Diseases (Bone Disease) 01/2021 - 05/2003
2	Breast Neoplasms (Breast Cancer) 10/2019 - 10/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 10/2011
1	Fatigue 08/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2022
1	Thromboembolism 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021
1	Febrile Neutropenia 10/2021
1	Cytopenia 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Pain (Aches) 12/2018
1	Stomatitis 12/2018
1	Death (Near-Death Experience) 10/2017
1	Thrombocytopenia (Thrombopenia) 09/2017
1	Neutropenia 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Amyloidosis 11/2015
1	Fever (Fevers) 01/2005
1	Exanthema (Rash) 01/2005
1	Oral Ulcer (Mouth Ulcer) 01/2005

Drug/Important Bio-Agent (IBA)

7	Proteasome InhibitorsIBA 01/2022 - 08/2008
6	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2010
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2010
5	Bortezomib (Velcade)FDA Link 01/2022 - 08/2008
4	Pharmaceutical PreparationsIBA 01/2022 - 06/2015
3	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2017
3	belantamab mafodotinIBA 01/2021 - 12/2020
3	Rituximab (Mabthera)FDA Link 01/2019 - 10/2011
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2004
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2018
2	Thalidomide (Thalomid)FDA Link 01/2022 - 09/2015
2	carfilzomibIBA 01/2022 - 01/2022
2	daratumumabIBA 01/2022 - 01/2019
2	link proteinIBA 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 07/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 12/2020 - 12/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 12/2018
2	NF-kappa B (NF-kB)IBA 07/2010 - 08/2008
2	Chemokine CCL3IBA 03/2005 - 05/2003
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	B-Cell Maturation AntigenIBA 01/2022
1	selinexorIBA 01/2022
1	trametinibIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	mesoglycanIBA 10/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Prostaglandins FIBA 10/2021
1	Fluconazole (Zonal)FDA LinkGeneric 10/2021
1	CD34 Antigens (CD34 Antigen)IBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	CytokinesIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	RadiopharmaceuticalsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Estrogen ReceptorsIBA 10/2019
1	Conditioned Culture MediaIBA 10/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	Pentostatin (Nipent)FDA LinkGeneric 01/2019
1	isatuximabIBA 01/2019
1	serum P-component (CIt)IBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2018
1	Narcotics (Narcotic Analgesics)IBA 12/2018
1	Vasoconstrictor AgentsIBA 12/2018
1	Versicans (Versican)IBA 01/2017
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 09/2015
1	Melphalan (Alkeran)FDA LinkGeneric 09/2015
1	Biological ProductsIBA 03/2012
1	denileukin diftitox (Ontak)FDA Link 03/2005
1	SteroidsIBA 03/2005
1	Chemokine ReceptorsIBA 03/2005
1	Interleukin-2 (IL2)IBA 03/2005

Therapy/Procedure

17	Therapeutics 09/2022 - 07/2004
7	Cell Transplantation 09/2022 - 08/2011
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
4	Stem Cell Transplantation 09/2017 - 07/2004
2	Induction Chemotherapy 01/2018 - 10/2011
2	Transplantation 08/2011 - 01/2005
1	Withholding Treatment 01/2022
1	Homologous Transplantation 11/2021
1	Length of Stay 10/2021
1	Parenteral Nutrition 10/2021
1	Hematopoietic Stem Cell Transplantation 10/2021
1	Immunotherapy 01/2017
1	Autologous Transplantation 11/2015